Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Damo logo — Empowering medical researchers with advanced data services a...

Damo

Empowering medical researchers with advanced data services and AI technology to enhance pharmaceutical innovation and promote industrial progress.

Founded 2016 Series A Total: $63.00M Big Data, Biotechnology +1

General Information

Company Name Damo
Founded Year 2016
Industries Big Data, Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when Damo moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Damo

Damo is a platform that aims to revolutionize the pharmaceutical industry by providing advanced data services and AI technology. Founded in 2016, the company's primary focus is on supporting medical researchers and promoting industrial progress. Damo facilitates research exchanges and collaboration among medical researchers, offering data services to pharmaceutical companies, CROs, and scientific research institutions. The most recent significant milestone for Damo was a CNY10.00M Series A investment on 08 August 2018, with the investment coming from 上海开物股权投资管理有限公司. Leveraging Big Data and Biotechnology expertise, Damo seeks to enhance the efficiency and effectiveness of scientific research, thereby contributing to the growth and innovation of the pharmaceutical industry. With a compelling slogan of "Empowering medical researchers with advanced data services and AI technology to enhance pharmaceutical innovation and promote industrial progress," Damo strives to bring disruptive changes to the field of pharmaceutical research.

Taxonomy: Pharmaceutical Innovation, Medical Research, Data Services, AI Technology, Research Exchanges, Industrial Progress, Scientific Research, CROs, Industrial Development

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
08 Aug 2018
Series A •••••• - 30 Jun 2017
Venture Round •••••• - 01 Jan 2017
Angel Round •••••• 1
Investor
01 Jun 2016

Damo Alternatives & Competitors

Damo vs
Clinvet
Clinvet South Africa

Research Innovation in Animal Health #ResearchInnovation #AnimalHealth

214 employees
Health Care, Pharmaceutical
Damo vs
RURO
RURO

Experience the future of laboratory management with innovative software for sample tracking, animal...

8 employees
Biotechnology
Damo vs
Precision Scientific
Precision Scientific China

Multi-omics Data Driven, Translational Medicine

21 employees

FAQ About Damo

Empowering medical researchers with advanced data services and AI technology to enhance pharmaceutical innovation and promote industrial progress.
Damo was founded in 2016.
Damo operates in the following industries: Big Data, Biotechnology, Pharmaceutical.
Damo has completed 4 funding rounds, raising a total of $63.00M. The latest funding stage is Series A.
Top alternatives and competitors to Damo include Clinvet, RURO, Precision Scientific, Thermo Scientific, CLUSTERNANOTECH LTD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Damo and Clinvet are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Damo and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy